Arkansas Children's Research institute
Little Rock, Arkansas 72202
8 studies enrolling now · 21 studies all time
What they study most
Acute Kidney Injury, Atopic Dermatitis, Bronchopulmonary Dysplasia of Newborn, COVID, COVID-19 Vaccines, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Duchene Muscular Dystrophy, High-grade Glioma, Immune System Diseases, Infant Nutrition, Insulin Resistance
Studies at this site
- Safety of MOON101 for the Treatment of Peanut Allergy — Recruiting now
- A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy — Recruiting now
- We-Move With Windy: Gross Motor Development for Early Childhood — Recruiting now
- Community Expecting: Exercise During Pregnancy — Recruiting now
- Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors — Recruiting now
- Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections — Recruiting now
- Child and Adolescent Registry for Participants With Narcolepsy — Recruiting now
- Long-term Antipsychotic Pediatric Safety Trial — Completed
- Longitudinal Prospective Study of Maternal and Child Nutrition in Arkansas — Starting soon
- Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia — Completed
- Allergic Disease Onset Prevention Study — Completed
- A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy — Running, not enrolling
- Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy — Stopped early
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy — Completed
- Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool — Completed
- Immunometabolism in Pediatric Obesity — Completed
- Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered — NO_LONGER_AVAILABLE
- Dissemination and Implementation of Stroke Prevention Looking at the Care Environment — Completed
- Pediatric Acute Kidney Injury in COVID-19 — Completed
- Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects — Stopped early
- Generations in Families Talking Safe Sleep — Status unconfirmed